Tevogen Bio Holdings Inc Evaluates Special Cash Dividend
Less than 1 min read
On January 30, 2026, Tevogen Bio Holdings Inc announced its Board's intention to evaluate a special cash dividend for shareholders.
Key Highlights:
- Dividend contingent on future financial milestones.
- Evaluation includes revenue and earnings targets.
- Subject to financial performance and capital needs.
- Final approval required from Board of Directors.
- No assurance on timing or amount of dividend.
Original SEC Filing: Tevogen Bio Holdings Inc. [ TVGN ] - 8-K - Jan. 30, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.